Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanistic Insights of Soluble Uric Acid-related Kidney Disease
Jing Pan, Min Shi, Liang Ma, et al.
Current Medicinal Chemistry (2018) Vol. 27, Iss. 30, pp. 5056-5066
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Update on the epidemiology, genetics, and therapeutic options of hyperuricemia.
Lijun Li, Yipeng Zhang, Changchun Zeng
PubMed (2020) Vol. 12, Iss. 7, pp. 3167-3181
Closed Access | Times Cited: 160
The Role of Oxidative Stress in Hyperuricemia and Xanthine Oxidoreductase (XOR) Inhibitors
Ning Liu, Hu Xu, Qianqian Sun, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 155
Research Advances in the Mechanisms of Hyperuricemia-Induced Renal Injury
Hong-yong Su, Chen Yang, Dong Liang, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-12
Open Access | Times Cited: 148
Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling
Qian Ren, Sibei Tao, Fan Guo, et al.
Phytomedicine (2021) Vol. 87, pp. 153552-153552
Closed Access | Times Cited: 79
The role of uric acid in inflammasome-mediated kidney injury
Tárcio Teodoro Braga, Orestes Foresto‐Neto, Niels Olsen Saraiva Câmara
Current Opinion in Nephrology & Hypertension (2020) Vol. 29, Iss. 4, pp. 423-431
Closed Access | Times Cited: 71
A Novel Approach Based on Gut Microbiota Analysis and Network Pharmacology to Explain the Mechanisms of Action of Cichorium intybus L. Formula in the Improvement of Hyperuricemic Nephropathy in Rats
Mukaram Amatjan, Na Li, Pengke He, et al.
Drug Design Development and Therapy (2023) Vol. Volume 17, pp. 107-128
Open Access | Times Cited: 22
Enzymatic and Non‐Enzymatic Uric Acid Electrochemical Biosensors: A Review
Miao Sun, Chuanjin Cui, Hongshuo Chen, et al.
ChemPlusChem (2023) Vol. 88, Iss. 9
Closed Access | Times Cited: 16
Mechanism of Lacticaseibacillus rhamnosus JY027 alleviating hyperuricemia in mice through gut-kidney axis
Chao Miao, Kai Dong, Yu Shen, et al.
Food Bioscience (2024) Vol. 61, pp. 104757-104757
Closed Access | Times Cited: 6
Pharmacological inhibition of fatty acid-binding protein 4 alleviated kidney inflammation and fibrosis in hyperuricemic nephropathy
Min Shi, Fan Guo, Dan Liao, et al.
European Journal of Pharmacology (2020) Vol. 887, pp. 173570-173570
Closed Access | Times Cited: 40
Ethanol extract of Liriodendron chinense (Hemsl.) Sarg barks attenuates hyperuricemic nephropathy by inhibiting renal fibrosis and inflammation in mice
Jing Pan, Chunle Zhang, Min Shi, et al.
Journal of Ethnopharmacology (2020) Vol. 264, pp. 113278-113278
Closed Access | Times Cited: 37
Overview of pharmacodynamical research of traditional Chinese medicine on hyperuricemic nephropathy: from the perspective of dual-regulatory effect on the intestines and kidneys
Ting Wang, Li Li, Liu Li, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Integrating network pharmacology and pharmacological validation to explore the effect of Shi Wei Ru Xiang powder on suppressing hyperuricemia
Qiang Li, Peng Liu, Chen Wu, et al.
Journal of Ethnopharmacology (2022) Vol. 298, pp. 115679-115679
Closed Access | Times Cited: 16
Construction of an uricase/catalase/curcumin-co-loaded drug delivery system and its effect on hyper-uric acid-induced kidney injury
Yang Zhang, Xiaobo Li, Chunling Liang, et al.
Smart Materials in Medicine (2024) Vol. 5, Iss. 3, pp. 321-335
Open Access | Times Cited: 3
The Extract of Sonneratia apetala Leaves and Branches Ameliorates Hyperuricemia in Mice by Regulating Renal Uric Acid Transporters and Suppressing the Activation of the JAK/STAT Signaling Pathway
Yulin Wu, Jinfen Chen, Linyun Jiang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 23
Therapeutic effects of traditional Chinese medicine on gouty nephropathy: Based on NF-κB signalingpathways
Peng Liu, Guijie Ma, Yang Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 158, pp. 114199-114199
Open Access | Times Cited: 8
Food-derived bio-functional peptides for the management of hyperuricemia and associated mechanism
Yanxin Wang, Mingxia Ma, Yumeng Huang, et al.
Deleted Journal (2023) Vol. 13, Iss. 4, pp. 1767-1786
Open Access | Times Cited: 7
Pharmacologic inhibiting STAT3 delays the progression of kidney fibrosis in hyperuricemia-induced chronic kidney disease
Jing Pan, Min Shi, Fan Guo, et al.
Life Sciences (2021) Vol. 285, pp. 119946-119946
Closed Access | Times Cited: 17
Serum Uric Acid Might Be Positively Associated With Hypertension in Chinese Adults: An Analysis of the China Health and Nutrition Survey
Yingdong Han, Kaidi Han, Xinxin Han, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 12
Racial Differences and Contributory Cardiovascular and Non-Cardiovascular Risk Factors Towards Chronic Kidney Disease Progression
Yuni Choi, David R. Jacobs, Holly Kramer, et al.
Vascular Health and Risk Management (2023) Vol. Volume 19, pp. 433-445
Open Access | Times Cited: 6
Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
Elisa Russo, Daniela Verzola, Giovanna Leoncini, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 819-819
Open Access | Times Cited: 14
Mechanism of Xiezhuo Huayu Yiqi Tongluo Formula in the Treatment of Uric Acid Nephropathy Based on Network Pharmacology, Molecular Docking, and In Vivo Experiments
Lifei Fan, Yuqin Guo, Qingmei Wu, et al.
Evidence-based Complementary and Alternative Medicine (2023) Vol. 2023, pp. 1-18
Open Access | Times Cited: 5
Bi Xie Fen Qing Yin decoction alleviates potassium oxonate and adenine induced-hyperuricemic nephropathy in mice by modulating gut microbiota and intestinal metabolites
Xianghao Lin, Xiaojuan Zou, Baifei Hu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116022-116022
Open Access | Times Cited: 5
Dietary Contributions to Metabolic Acidosis
Lynda Frassetto, Thomas Remer, Tanushree Banerjee
Advances in Chronic Kidney Disease (2022) Vol. 29, Iss. 4, pp. 373-380
Closed Access | Times Cited: 8
Effect of high-altitude hypoxia environment on uric acid excretion, Desmin protein level in podocytes, and Na+-K+- ATPase activity
Yi Du, Mei Qi, Wenli Wang, et al.
Cellular and Molecular Biology (2022) Vol. 68, Iss. 6, pp. 84-91
Open Access | Times Cited: 8
Spike lavender essential oil attenuates hyperuricemia and induced renal injury by modulating the TLR4/NF-κB/NLRP3 signalling pathway
Peijie Zhou, Biao Zhang, Xuan Wang, et al.
Arabian Journal of Chemistry (2024) Vol. 17, Iss. 9, pp. 105897-105897
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top